Related Experiment Video
Updated: Aug 20, 2025

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
Published on: June 12, 2021
Stk10 Deficiency in Mice Promotes Tumor Growth by Dysregulating the Tumor Microenvironment
Jin-Xia Ma1, Dan-Dan Xu1, Shun-Yuan Lu1
1Research Center for Experimental Medicine, State Key Laboratory of Medical Genomics, Shanghai Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Abstract:
Serine-threonine kinase 10 (STK10) is a member of the STE20/p21-activated kinase (PAK) family and is predominantly expressed in immune organs. Our previous reports suggested that STK10 participates in the growth and metastasis of prostate cancer via in vitro and in vivo data. However, the correlation between STK10 and the tumor microenvironment (TME) remains unclear. In this study, we assessed the relationship between STK10 and the immune cells in the tumor microenvironment of prostate cancer through bioinformatic analysis, and investigated the role of Stk10 in tumor growth using an Stk10 knockout mouse model. The results showed that STK10 is significantly associated with the tumor-infiltrating immune cells including lymphocytes, neutrophils, macrophages and dendritic cells. The target deletion of host Stk10 results in increased tumor growth, due to decreased activated/effector cytotoxic T lymphocytes (CTLs) and increased vessel density in the TME. In conclusion, we demonstrate that host Stk10 is involved in the host anti-tumor response by modulating the activated tumor-infiltrated CTLs and angiogenesis.
Insights
Serine-threonine kinase 10 (STK10) influences prostate cancer growth by modulating immune cells in the tumor microenvironment. Deleting STK10 impairs anti-tumor immunity, increasing tumor growth and angiogenesis.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Serine-threonine kinase 10 (STK10), a STE20/p21-activated kinase (PAK) family member, is expressed in immune organs.
- Previous studies indicated STK10's role in prostate cancer growth and metastasis.
- The relationship between STK10 and the tumor microenvironment (TME) in prostate cancer is not well understood.
Purpose of the Study:
- To investigate the association between STK10 and immune cells within the prostate cancer TME.
- To determine the role of STK10 in tumor growth using a knockout mouse model.
Main Methods:
- Bioinformatic analysis to assess STK10's relationship with tumor-infiltrating immune cells.
- Utilizing an *Stk10* knockout mouse model to study tumor growth dynamics.
Main Results:
- STK10 expression is significantly correlated with tumor-infiltrating lymphocytes, neutrophils, macrophages, and dendritic cells.
- Deletion of host *Stk10* led to accelerated tumor growth.
- This accelerated growth was associated with reduced activated/effector cytotoxic T lymphocytes (CTLs) and increased TME vessel density.
Conclusions:
- Host STK10 plays a crucial role in the anti-tumor immune response.
- STK10 modulates activated tumor-infiltrated CTLs and angiogenesis, impacting tumor progression.
Related Concept Videos
The Tumor Microenvironment
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

